Skip to main content
Nath Biogene India Ltd. logo

Nath Biogene India Ltd. — Investor Relations & Filings

Ticker · NATHBIOGEN ISIN · INE448G01010 BSE.NS Agriculture, forestry and fishing
Filings indexed 450 across all filing types
Latest filing 2021-03-30 Regulatory Filings
Country IN India
Listing BSE.NS NATHBIOGEN

About Nath Biogene India Ltd.

https://www.nathbiogenes.com

Nath Biogene India Ltd. specializes in the research, development, production, and marketing of high-quality hybrid seeds. The company maintains a diverse product portfolio encompassing field crops such as cotton, paddy, maize, jowar, and bajra, alongside a wide range of vegetable seeds including tomato, okra, and chili. With a strong emphasis on biotechnological innovation and plant breeding, the organization focuses on developing high-yielding, pest-resistant, and climate-resilient seed varieties to enhance agricultural productivity. Its operations are supported by extensive research and development facilities and a robust distribution network that ensures the delivery of advanced genetic materials to farming communities. The company leverages its technical expertise to provide integrated solutions aimed at improving crop quality and farmer profitability through sustainable agricultural practices.

Recent filings

Filing Released Lang Actions
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document text contains only placeholders for images and no substantive text or financial data. The true document length is only 168 characters, indicating it is extremely short and does not contain any report content. There is no indication of any report, announcement, or filing type. Given the lack of content, this document best fits the fallback category for miscellaneous or non-informative filings, which is Regulatory Filings (RNS).
2021-03-30 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 100% confidence The document text is extremely short (63 characters) and contains no substantive content, only a placeholder for an omitted picture. There is no financial data, report content, or any indication of report type. Given the lack of information and content, this document does not fit any specific report category and defaults to Regulatory Filings (RNS) as a fallback category.
2021-03-15 English
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification Classification · 100% confidence The document is a disclosure under regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeover) Regulations, 2011. It details the creation of pledge on shares by a promoter entity (Agri-Tech (India) Limited) of the company Nath Bio-Genes (India) Limited. The content focuses on share encumbrance information, which is a notification about changes in shareholding or encumbrance status by promoters. This type of filing corresponds to a Major Shareholding Notification (MRQ) as it involves disclosure of substantial acquisition or encumbrance of shares by promoters as per SEBI regulations. The document is not a financial report, earnings release, or management discussion, but a regulatory disclosure about shareholding changes.
2021-02-19 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2021-02-17 English
Investor Presentation
Regulatory Filings
2021-02-12 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 60% confidence The document text is extremely short (720 characters) and mostly consists of access numbers and PINs for telephone participation, with no substantive financial data, report content, or detailed information. It appears to be related to a conference call or telephonic event access information rather than a full transcript or report. There is no indication of financial results, management discussion, or regulatory filings. Given the presence of access numbers and PINs, this is likely related to a Call Transcript or conference call event. However, since the actual transcript text is missing and only access details are provided, it is not a full Call Transcript (CT). The document does not fit other categories and is closest to a Call Transcript (CT) in purpose, but incomplete. Given the lack of actual transcript content, the best classification is Regulatory Filings (RNS) as a fallback for miscellaneous filings that do not fit elsewhere, with moderate confidence.
2021-02-11 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.